Anti-PLA 2R antibodies in membranous nephropathy: Ready for routine clinical practice?

Netherlands Journal of Medicine

Volumn 70, Issue 3, 2012, Pages 109-113

  Hofstra, J M ^a   Wetzels, J F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti PLA 2R; Membranous nephropathy; Nephrotic syndrome

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR;

CLINICAL PRACTICE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOFLUORESCENCE; KIDNEY TRANSPLANTATION; LIMIT OF QUANTITATION; MEMBRANOUS GLOMERULONEPHRITIS; RECURRENT DISEASE; REVIEW; WESTERN BLOTTING;

AUTOANTIBODIES; BIOLOGICAL MARKERS; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; RECEPTORS, PHOSPHOLIPASE A2; SEVERITY OF ILLNESS INDEX;

EID: 84860144475     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Tiebosch AT, Wolters J, Frederik PF, et al. Epidemiology of idiopathic glomerular disease: a prospective study. Kidney Int. 1987;32(1):112-116.
2. Debiec H, Ronco P. Fetomaternal alloimmunization with antenatal glomerulopathies. Ann N Y Acad Sci. 2007;1110:559-566.
3. Beck LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11-21.
4. Stanescu HC, Arcos-Burgos M, Medlar A, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011; 364(7):616-626.
5. Glassock RJ. Human idiopathic membranous nephropathy--a mystery solved? N Engl J Med. 2009;361(1):81-83.
6. Hoxha E, Harendza S, Zahner G, et al. An immunofuorescence test for phospholipase-A-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant. 2011;26(8):2526-2532.
7. Kanigicherla DKA, Brenchley PE, Venning M, et al. Association of Anti-PLA2R with Disease Activity and Outcome in Idiopathic Membranous Nephropathy [Abstract]. J Am Soc Nephrol. 2011;22:33A.
8. Qin W, Beck LH, Jr., Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol. 2011;22(6):1137-1143.
9. Schönermarck U, Eichhorn P, Sitter T, et al. Performance of Anti-Phospholipase A2-Receptor Antibody Testing for Membranous Nephropathy in Routine Clinical Practice [Abstract]. J Am Soc Nephrol. 2011;22:775A.
10. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med. 2011;364(7):689-690.
11. Hoxha E, Zahner G, Velden J, et al. Phospholipase A2 Receptor Autoantibodies (PLA2R-AB) and Increased PLA2R Expression in Glomeruli Discriminate Primary from Secondary Membranous Nephropathy (MN) [Abstract]. J Am Soc Nephrol. 2011;22:68A.
12. Ma H, Beck LH, Salant DJ. Membranous Nephropathy-Associated Anti-Phospholipase A2 Receptor IgG4 Autoantibodies Activate the Lectin Complement Pathway [Abstract]. J Am Soc Nephrol. 2011;22:62A.
13. Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transplant 2011; doi: 10.1093/ndt/gfr534.
14. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant. 2006;6(11):2535-2542.
15. Stahl R, Hoxha E, Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med. 2010;363(5):496-498.
16. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specifc for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant. 2011;11(10):2144-2152.
17. Hofstra JM, Beck LH, Beck DM, et al. Anti-phospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286-1291.
18. Beck LH, Fervenza FC, Beck DM, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol. 2011;22(8):1543-1550.
19. Hofstra JM, Wetzels JF. Management of patients with membranous nephropathy. Nephrol Dial Transplant. 2011; doi: 10.1093/ndt/gfr371.
20. Bruschi M, Carnevali ML, Murtas C, et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. J Proteomics. 2011 Sep 6;74(10):2008-2017.
21. Beck LH, Jr., Fervenza FC, Bomback AS, et al. Response of Anti-PLA2R to Adrenocorticotropic Hormone (ACTH) Gel in Membranous Nephropathy [Abstract]. J Am Soc Nephrol. 2011;22:33A.
22. Knehtl M, Debiec H, Kamgang P, et al. A case of phospholipase A receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis. 2011;57(1):140-143.